Subscribe
Sign in
Home
Work with us / Advertise
CensHERship
Archive
About
Latest
Top
Discussions
Sun Pharma to acquire Organon in $11.75bn deal, strengthening global women's health platform
Organon has one of the largest dedicated women's health portfolios globally
23 hrs ago
•
Anna O'Sullivan
4
1
Why the bone health market is moving earlier
Bone health is converging with the longevity boom
Apr 24
•
Anna O'Sullivan
17
💌 Issue 143: ENDOSURE gets CE mark | Septagen launches to tackle cardiovascular risk | Osteoboost raises $8m
The global weekly briefing on women's health innovation and Femtech
Apr 22
•
Anna O'Sullivan
18
1
Women’s health wearables 2026 report: A full-body map
FFHi report: the leading devices, use cases and companies innovating in the wearables space.
Apr 22
•
Anna O'Sullivan
and
Anastasiya Markvarde
11
4
2
Carea launches miscarriage support feature to address gaps in NHS care and pregnancy apps
Health Secretary Wes Streeting has recently acknowledged that support for pregnancy loss has “traditionally been lacking”
Apr 22
•
Anna O'Sullivan
ENDOSURE's endometriosis diagnostic test receives CE mark for use across Europe
Positioned as first test that can be used by younger teens and postmenopausal women
Apr 21
•
Anna O'Sullivan
2
1
First confirmed pregnancy using BAIBYS' AI system that selects and isolates sperm in IVF
Automated lab processes are supporting improved precision and consistency in IVF
Apr 21
•
Anna O'Sullivan
1
Reproductive health gaps persist across generations, new survey finds
Gaps in knowledge, diagnosis and care have remained largely unchanged
Apr 21
•
Anna O'Sullivan
2
1
Vanderbilt University spinout Septagen launches to target overlooked driver of women’s heart disease
Addressing a leading cause of death in women
Apr 21
•
Anna O'Sullivan
Q1 funding: what $1.24b into women’s health really tells us
Platform expansion, deep tech, and why the category is starting to blur
Apr 17
•
Anna O'Sullivan
28
2
FertilAI secures CE mark for predictive AI tools targeting fertility treatment timing
The newly cleared platform focuses on one of the most complex and variable aspects of fertility treatment
Apr 16
•
Anna O'Sullivan
2
Osteoboost raises $8m to scale FDA-cleared wearable targeting bone loss in postmenopausal women
Interest grows in non-drug interventions for age-related conditions
Apr 15
•
Anna O'Sullivan
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
